{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:35:37Z","timestamp":1789763737661,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41401-019-0217-9","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:16:50Z","timestamp":1551266210000},"page":"1138-1156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis"],"prefix":"10.1038","volume":"40","author":[{"given":"Yuan-qiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-zi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Qun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"217_CR1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","volume":"195","author":"J Hannon","year":"2008","unstructured":"Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res. 2008;195:198\u2013213.","journal-title":"Behav Brain Res"},{"key":"217_CR2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.neuron.2014.07.002","volume":"83","author":"IP Dorocic","year":"2014","unstructured":"Dorocic IP, F\u00fcrth D, Xuan Y, Johansson Y, Pozzi L, Silberberg G, et al. A whole-brain atlas of inputs to serotonergic neurons of the dorsal and median raphe nuclei. Neuron. 2014;83:663\u201378.","journal-title":"Neuron"},{"key":"217_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-2999(98)00744-4","volume":"361","author":"BJ Francken","year":"1998","unstructured":"Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE. The human 5-ht5A receptor couples to Gi\/Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur J Pharmacol. 1998;361:299\u2013309.","journal-title":"Eur J Pharmacol"},{"key":"217_CR4","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2174\/138955711797655353","volume":"11","author":"V Pittala","year":"2011","unstructured":"Pittala V, Pittala D. Latest advances towards the discovery of 5-HT7 receptor ligands. Mini Rev Med Chem. 2011;11:1108\u201321.","journal-title":"Mini Rev Med Chem"},{"key":"217_CR5","doi-asserted-by":"crossref","unstructured":"Tseng K-Y, Atzori M. Monoaminergic modulation of cortical excitability. (Springer, New York, 2007).","DOI":"10.1007\/978-0-387-72256-6"},{"key":"217_CR6","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1021\/jm5019274","volume":"58","author":"J Cheng","year":"2015","unstructured":"Cheng J, Gigu\u00e8re PM, Onajole OK, Lv W, Gaisin A, Gunosewoyo H, et al. Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents. J Med Chem. 2015;58:1992\u20132002.","journal-title":"J Med Chem"},{"key":"217_CR7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1523\/JNEUROSCI.2830-16.2016","volume":"37","author":"V Beliveau","year":"2017","unstructured":"Beliveau V, Ganz M, Feng L, Ozenne B, H\u00f8jgaard L, Fisher PM, et al. A high-resolution in vivo atlas of the human brain\u2019s serotonin system. J Neurosci. 2017;37:120\u20138.","journal-title":"J Neurosci"},{"key":"217_CR8","doi-asserted-by":"crossref","unstructured":"Kim S-K, Goddard WA III. Molecular-docking-based drug design and discovery: rational drug design for the subtype selective GPCR ligands. In: Applied Case Studies and Solutions in Molecular Docking-Based Drug Design (Siavoush Dastmalchican ed.). IGI Global; 2016, p. 158\u201385.","DOI":"10.4018\/978-1-5225-0362-0.ch006"},{"key":"217_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1385\/MN:29:1:31","volume":"29","author":"M Noda","year":"2004","unstructured":"Noda M, Higashida H, Aoki S, Wada K. Multiple signal transduction pathways mediated by 5-HT receptors. Mol Neurobiol. 2004;29:31\u20139.","journal-title":"Mol Neurobiol"},{"key":"217_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11594710-000000000-00000","volume":"26","author":"E Spina","year":"2012","unstructured":"Spina E, Trifir\u00f2 G, Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs. 2012;26:39\u201367.","journal-title":"CNS Drugs"},{"key":"217_CR11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.genm.2010.04.006","volume":"7","author":"EA MacGregor","year":"2010","unstructured":"MacGregor EA, Pawsey SP, Campbell JC, Hu X. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: results of a new analysis of data from five previously published studies. Gend Med. 2010;7:88\u2013108.","journal-title":"Gend Med"},{"key":"217_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02245439","volume":"114","author":"A Megens","year":"1994","unstructured":"Megens A, Awouters F, Schotte A, Meert T, Dugovic C, Niemegeers C, et al. Survey on the pharmacodynamics of the new antipsychotic risperidone. Psychopharmacology. 1994;114:9\u201323.","journal-title":"Psychopharmacology"},{"key":"217_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","volume":"6","author":"DD Han","year":"2006","unstructured":"Han DD, Gu HH. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 2006;6:6.","journal-title":"BMC Pharmacol"},{"key":"217_CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pneurobio.2007.01.001","volume":"81","author":"CP M\u00fcller","year":"2007","unstructured":"M\u00fcller CP, Carey RJ, Huston JP, De Souza Silva MA. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog Neurobiol. 2007;81:133\u201378.","journal-title":"Prog Neurobiol"},{"key":"217_CR15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/187152708786927886","volume":"7","author":"E Engleman","year":"2008","unstructured":"Engleman E, Rodd Z, Bell R, Murphy J. The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. CNS Neurol Disord Drug Targets. 2008;7:454\u201367.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"217_CR16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1126\/science.1232807","volume":"340","author":"C Wang","year":"2013","unstructured":"Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, et al. Structural basis for molecular recognition at serotonin receptors. Science. 2013;340:610\u20134.","journal-title":"Science"},{"key":"217_CR17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1232808","volume":"340","author":"D Wacker","year":"2013","unstructured":"Wacker D, Wang C, Katritch V, Han GW, Huang X-P, Vardy E, et al. Structural features for functional selectivity at serotonin receptors. Science. 2013;340:615\u20139.","journal-title":"Science"},{"key":"217_CR18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cell.2018.01.001","volume":"172","author":"Y Peng","year":"2018","unstructured":"Peng Y, McCorvy JD, Harps\u00f8e K, Lansu K, Yuan S, Popov P, et al. 5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology. Cell. 2018;172:719\u201330. e14.","journal-title":"Cell"},{"key":"217_CR19","doi-asserted-by":"crossref","first-page":"5.6. 1","DOI":"10.1002\/0471250953.bi0506s15","volume":"15","author":"N Eswar","year":"2006","unstructured":"Eswar N, Webb B, Marti\u2010Renom MA, Madhusudhan M, Eramian D, My Shen, et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinf. 2006;15:5.6. 1\u20135.6. 30.","journal-title":"Curr Protoc Bioinf"},{"key":"217_CR20","doi-asserted-by":"crossref","first-page":"D440","DOI":"10.1093\/nar\/gkx1109","volume":"46","author":"G P\u00e1ndy-Szekeres","year":"2017","unstructured":"P\u00e1ndy-Szekeres G, Munk C, Tsonkov TM, Mordalski S, Harps\u00f8e K, Hauser AS, et al. GPCRdb in 2018: adding GPCR structure models and ligands. Nucleic Acids Res. 2017;46:D440\u2013D6.","journal-title":"Nucleic Acids Res"},{"key":"217_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00124474","volume":"10","author":"AN Jain","year":"1996","unstructured":"Jain AN. Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aid Mol Des. 1996;10:427\u201340.","journal-title":"J Comput Aid Mol Des"},{"key":"217_CR22","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/ci7000814","volume":"47","author":"JZ Chen","year":"2007","unstructured":"Chen J-Z, Wang J, Xie X-Q. GPCR structure-based virtual screening approach for CB2 antagonist search. J Chem Inf Model. 2007;47:1626\u201337.","journal-title":"J Chem Inf Model"},{"key":"217_CR23","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1021\/ci5002718","volume":"54","author":"Z Feng","year":"2014","unstructured":"Feng Z, Alqarni MH, Yang P, Tong Q, Chowdhury A, Wang L, et al. Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs. J Chem Inf Model. 2014;54:2483\u201399.","journal-title":"J Chem Inf Model"},{"key":"217_CR24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12154-015-0131-7","volume":"8","author":"Z Feng","year":"2015","unstructured":"Feng Z, Kochanek S, Close D, Wang L, Srinivasan A, Almehizia AA, et al. Design and activity of AP endonuclease-1 inhibitors. J Chem Biol. 2015;8:79\u201393.","journal-title":"J Chem Biol"},{"key":"217_CR25","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1021\/ci5002718","volume":"54","author":"Z Feng","year":"2015","unstructured":"Feng Z, Pearce LV, Xu X, Yang X, Yang P, Blumberg PM, et al. Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening and bioassay validations. J Chem Inf Model. 2015;54:2483\u201399.","journal-title":"J Chem Inf Model"},{"key":"217_CR26","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11:3696\u2013713.","journal-title":"J Chem Theory Comput"},{"key":"217_CR27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926\u201335.","journal-title":"J Chem Phys"},{"key":"217_CR28","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","volume":"23","author":"A Jakalian","year":"2002","unstructured":"Jakalian A, Jack DB, Bayly CI. Fast, efficient generation of high\u2010quality atomic charges. AM1\u2010BCC model: II. Parameterization and validation. J Comput Chem. 2002;23:1623\u201341.","journal-title":"J Comput Chem"},{"key":"217_CR29","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem. 2004;25:1157\u201374.","journal-title":"J Comput Chem"},{"key":"217_CR30","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1021\/ct200909j","volume":"8","author":"AW Go\u0308tz","year":"2012","unstructured":"Go\u0308tz AW, Williamson MJ, Xu D, Poole D, Le Grand S, Walker RC. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J Chem Theory Comput. 2012;8:1542\u201355.","journal-title":"J Chem Theory Comput"},{"key":"217_CR31","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Go\u0308tz AW, Poole D, Le Grand S, Walker RC. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J Chem Theory Comput. 2013;9:3878\u201388.","journal-title":"J Chem Theory Comput"},{"key":"217_CR32","unstructured":"Case D.A., Betz R.M., Cerutti D.S., Cheatham T.E., III, Darden T.A., Duke R.E. et al. AMBER 2016, University of California, San Francisco. 2016"},{"key":"217_CR33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/bip.360320508","volume":"32","author":"RJ Loncharich","year":"1992","unstructured":"Loncharich RJ, Brooks BR, Pastor RW. Langevin dynamics of peptides: the frictional dependence of isomerization rates of N\u2010acetylalanyl\u2010N\u2032\u2010methylamide. Biopolymers. 1992;32:523\u201335.","journal-title":"Biopolymers"},{"key":"217_CR34","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1063\/1.1332996","volume":"114","author":"JA Izaguirre","year":"2001","unstructured":"Izaguirre JA, Catarello DP, Wozniak JM, Skeel RD. Langevin stabilization of molecular dynamics. J Chem Phys. 2001;114:2090\u20138.","journal-title":"J Chem Phys"},{"key":"217_CR35","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L. Particle mesh Ewald: an N\u22c5 log (N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089\u201392.","journal-title":"J Chem Phys"},{"key":"217_CR36","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys. 1995;103:8577\u201393.","journal-title":"J Chem Phys"},{"key":"217_CR37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"JP Ryckaert","year":"1977","unstructured":"Ryckaert J-P, Ciccotti G, Berendsen HJ. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1977;23:327\u201341.","journal-title":"J Comput Phys"},{"key":"217_CR38","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1021\/ci300064d","volume":"52","author":"J Wang","year":"2012","unstructured":"Wang J, Hou T. Develop and test a solvent accessible surface area-based model in conformational entropy calculations. J Chem Inf Model. 2012;52:1199\u2013212.","journal-title":"J Chem Inf Model"},{"key":"217_CR39","doi-asserted-by":"crossref","first-page":"19824","DOI":"10.1021\/jp961710n","volume":"100","author":"GD Hawkins","year":"1996","unstructured":"Hawkins GD, Cramer CJ, Truhlar DG. Parametrized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium. J Phys Chem. 1996;100:19824\u201339.","journal-title":"J Phys Chem"},{"key":"217_CR40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000;33:889\u201397.","journal-title":"Acc Chem Res"},{"key":"217_CR41","doi-asserted-by":"crossref","first-page":"14450","DOI":"10.1039\/C7CP07623A","volume":"20","author":"H Sun","year":"2018","unstructured":"Sun H, Duan L, Chen F, Liu H, Wang Z, Pan P, et al. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches. Phys Chem Chem Phys. 2018;20:14450\u201360.","journal-title":"Phys Chem Chem Phys"},{"key":"217_CR42","doi-asserted-by":"crossref","first-page":"22129","DOI":"10.1039\/C6CP03670H","volume":"18","author":"F Chen","year":"2016","unstructured":"Chen F, Liu H, Sun H, Pan P, Li Y, Li D, et al. Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 6. Capability to predict protein\u2013protein binding free energies and re-rank binding poses generated by protein\u2013protein docking. Phys Chem Chem Phys. 2016;18:22129\u201339.","journal-title":"Phys Chem Chem Phys"},{"key":"217_CR43","doi-asserted-by":"crossref","first-page":"22035","DOI":"10.1039\/C4CP03179B","volume":"16","author":"H Sun","year":"2014","unstructured":"Sun H, Li Y, Shen M, Tian S, Xu L, Pan P, et al. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM\/GBSA and MM\/PBSA rescoring. Phys Chem Chem Phys. 2014;16:22035\u201345.","journal-title":"Phys Chem Chem Phys"},{"key":"217_CR44","doi-asserted-by":"crossref","first-page":"16719","DOI":"10.1039\/C4CP01388C","volume":"16","author":"H Sun","year":"2014","unstructured":"Sun H, Li Y, Tian S, Xu L, Hou TJPCCP. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys Chem Chem Phys. 2014;16:16719\u201329.","journal-title":"Phys Chem Chem Phys"},{"key":"217_CR45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E","volume":"56","author":"V Tsui","year":"2000","unstructured":"Tsui V, Case DA. Theory and applications of the generalized born solvation model in macromolecular simulations. Biopolymers . 2000;56:275\u201391.","journal-title":"Biopolymers"},{"key":"217_CR46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.physchem.51.1.129","volume":"51","author":"D Bashford","year":"2000","unstructured":"Bashford D, Case DA. Generalized born models of macromolecular solvation effects. Annu Rev Phys Chem. 2000;51:129\u201352.","journal-title":"Annu Rev Phys Chem"},{"key":"217_CR47","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/j100058a043","volume":"98","author":"D Sitkoff","year":"1994","unstructured":"Sitkoff D, Sharp KA, Honig B. Accurate calculation of hydration free energies using macroscopic solvent models. J Phys Chem. 1994;98:1978\u201388.","journal-title":"J Phys Chem"},{"key":"217_CR48","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1021\/ja00172a038","volume":"112","author":"WC Still","year":"1990","unstructured":"Still WC, Tempczyk A, Hawley RC, Hendrickson T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc. 1990;112:6127\u20139.","journal-title":"J Am Chem Soc"},{"key":"217_CR49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","volume":"20","author":"J Weiser","year":"1999","unstructured":"Weiser J, Shenkin PS, Still WC. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem. 1999;20:217\u201330.","journal-title":"J Comput Chem"},{"key":"217_CR50","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/acs.jcim.5b00739","volume":"56","author":"J Hu","year":"2016","unstructured":"Hu J, Feng Z, Ma S, Zhang Y, Tong Q, Alqarni MH, et al. Difference and influence of inactive and active states of cannabinoid receptor subtype CB2: from conformation to drug discovery. J Chem Inf Model. 2016;56:1152\u201363.","journal-title":"J Chem Inf Model"},{"key":"217_CR51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jmgm.2016.08.001","volume":"70","author":"X Xu","year":"2016","unstructured":"Xu X, Ma S, Feng Z, Hu G, Wang L, Xie X-QJJoMG, et al. Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification\u2014salvinorin A as a case study. J Mol Graph Model. 2016;70:284\u201395.","journal-title":"J Mol Graph Model"},{"key":"217_CR52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1208\/s12248-012-9449-z","volume":"15","author":"L Wang","year":"2013","unstructured":"Wang L, Ma C, Wipf P, Liu H, Su W, Xie X-QJTAj. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database. AAPS J. 2013;15:395\u2013406.","journal-title":"AAPS J"},{"key":"217_CR53","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ci500004h","volume":"54","author":"H Liu","year":"2014","unstructured":"Liu H, Wang L, Lv M, Pei R, Li P, Pei Z, et al. AlzPlatform: an Alzheimer\u2019s disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research. J Chem Inf Model. 2014;54:1050\u201360.","journal-title":"J Chem Inf Model"},{"key":"217_CR54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/aps.2017.85","volume":"39","author":"Y Xue","year":"2018","unstructured":"Xue Y, Feng Z-w, Li X-y, Hu Z-h, Xu Q, Wang Z, et al. The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis. Acta Pharmacol Sin. 2018;39:205.","journal-title":"Acta Pharmacol Sin"},{"key":"217_CR55","volume":"6","author":"H Zhang","year":"2016","unstructured":"Zhang H, Ma S, Feng Z, Wang D, Li C, Cao Y, et al. Cardiovascular disease chemogenomics knowledgebase-guided target identification and drug synergy mechanism study of an herbal formula. Sci Rep. 2016;6:33963.","journal-title":"Sci Rep"},{"key":"217_CR56","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"217_CR57","first-page":"216","volume":"283","author":"L Johansson","year":"1997","unstructured":"Johansson L, Sohn D, Thorberg SO, Jackson DM, Kelder D, Larsson LG, et al. The pharmacological characterization of a novel selective 5-hydroxytryptamine(1A) receptor antagonist, NAD-299. J Pharmacol Exp Ther. 1997;283:216\u201325.","journal-title":"J Pharmacol Exp Ther"},{"key":"217_CR58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0014-2999(99)00262-9","volume":"375","author":"DN Middlemiss","year":"1999","unstructured":"Middlemiss DN, Gothert M, Schlicker E, Scott CM, Selkirk JV, Watson J, et al. SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor. Eur J Pharmacol. 1999;375:359\u201365.","journal-title":"Eur J Pharmacol"},{"key":"217_CR59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2015.01.043","volume":"751","author":"B Schmitz","year":"2015","unstructured":"Schmitz B, Ullmer C, Segelcke D, Gwarek M, Zhu XR, Lubbert H. BF-1-A novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs. Eur J Pharmacol. 2015;751:73\u201380.","journal-title":"Eur J Pharmacol"},{"key":"217_CR60","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","volume":"36","author":"GA Kennett","year":"1997","unstructured":"Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, et al. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology. 1997;36:609\u201320.","journal-title":"Neuropharmacology"},{"key":"217_CR61","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/sj.bjp.0701851","volume":"124","author":"AJ Sleight","year":"1998","unstructured":"Sleight AJ, Boess FG, Bos M, Levet-Trafit B, Riemer C, Bourson A. Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors. Br J Pharmacol. 1998;124:556\u201362.","journal-title":"Br J Pharmacol"},{"key":"217_CR62","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/S0960-894X(02)00690-X","volume":"12","author":"IT Forbes","year":"2002","unstructured":"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, et al. SB-656104-A: a novel 5-HT7 receptor antagonist with improved in vivo properties. Bioorg Med Chem Lett. 2002;12:3341\u20134.","journal-title":"Bioorg Med Chem Lett"},{"key":"217_CR63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.forsciint.2004.08.004","volume":"152","author":"MA Alabdalla","year":"2005","unstructured":"Alabdalla MA. Chemical characterization of counterfeit captagon tablets seized in Jordan. Forensic Sci Int. 2005;152:185\u20138.","journal-title":"Forensic Sci Int"},{"key":"217_CR64","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3109\/10826084.2014.913633","volume":"49","author":"NJ Al-Hemiary","year":"2014","unstructured":"Al-Hemiary NJ, Al-Diwan JK, Hasson AL, Rawson RA. Drug and alcohol use in Iraq: findings of the inaugural Iraqi Community Epidemiological Workgroup. Subst Use Misuse. 2014;49:1759\u201363.","journal-title":"Subst Use Misuse"},{"key":"217_CR65","first-page":"133","volume":"119","author":"M Katselou","year":"2016","unstructured":"Katselou M, Papoutsis I, Nikolaou P, Qammaz S, Spiliopoulou C, Athanaselis S. Fenethylline (Captagon) abuse\u2013local problems from an old drug become universal. Basic. Clin Pharmacol. 2016;119:133\u201340.","journal-title":"Clin Pharmacol"},{"key":"217_CR66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0376-8716(86)90012-8","volume":"17","author":"G Kristen","year":"1986","unstructured":"Kristen G, Schaefer A, Von Schlichtegroll A. Fenetylline: therapeutic use, misuse and\/or abuse. Drug Alcohol Depen. 1986;17:259\u201371.","journal-title":"Drug Alcohol Depen"},{"key":"217_CR67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/add.13262","volume":"111","author":"MC Hout Van","year":"2016","unstructured":"Van Hout MC, Wells J. Is Captagon (fenethylline) helping to fuel the Syrian conflict? Addiction. 2016;111:748\u20139.","journal-title":"Addiction"},{"key":"217_CR68","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nature23464","volume":"548","author":"CJ Wenthur","year":"2017","unstructured":"Wenthur CJ, Zhou B, Janda KD. Vaccine-driven pharmacodynamic dissection and mitigation of fenethylline psychoactivity. Nature. 2017;548:476\u20139.","journal-title":"Nature"},{"key":"217_CR69","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/ci100399j","volume":"51","author":"C Ma","year":"2011","unstructured":"Ma C, Wang L, Xie X-Q. Ligand classifier of adaptively boosting ensemble decision stumps (LiCABEDS) and its application on modeling ligand functionality for 5HT-subtype GPCR families. J Chem Inf Model. 2011;51:521\u201331.","journal-title":"J Chem Inf Model"},{"key":"217_CR70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/ci3003914","volume":"53","author":"C Ma","year":"2013","unstructured":"Ma C, Wang L, Yang P, Myint KZ, Xie X-Q. LiCABEDS II. Modeling of ligand selectivity for G-protein-coupled cannabinoid receptors. J Chem Inf Model. 2013;53:11\u201326.","journal-title":"J Chem Inf Model"},{"key":"217_CR71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/ci600312d","volume":"47","author":"YH Zhao","year":"2007","unstructured":"Zhao YH, Abraham MH, Ibrahim A, Fish PV, Cole S, Lewis ML, et al. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes. J Chem Inf Model. 2007;47:170\u20135.","journal-title":"J Chem Inf Model"},{"key":"217_CR72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0376-8716(86)90011-6","volume":"17","author":"B Nickel","year":"1986","unstructured":"Nickel B, Niebch G, Peter G, Von Schlichtegroll A, Tibes U. Fenetylline: new results on pharmacology, metabolism and kinetics. Drug Alcohol Depend. 1986;17:235\u201357.","journal-title":"Drug Alcohol Depend"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0217-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:50Z","timestamp":1684616510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0217-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0217-9","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"28 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X-QX is the Founder of ID4Pharma and serves as a consultant for Oxis Biotech. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}